Pfizer
PFE
$40.22
Share price
-0.42%
Change (1 day)
-24.51%
Change (1 year)
Categories
Pfizer Inc., is a global pharmaceutical company headquartered in New York City, New York, United States. It was founded by Charles Pfizer from Ludwigsburg. Pfizer is the second largest pharmaceutical company in the world after Roche, followed by Novartis.
P/S ratio for Pfizer (PFE)
P/S ratio as of March 2023 (TTM): 2.26
According to Pfizer's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.26381. At the end of 2022 the company had a P/S ratio of 2.87.
P/S ratio history for Pfizer from 2001 to 2022
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2022 | 2.87 | -29.69% |
| 2021 | 4.08 | -16.49% |
| 2020 | 4.88 | 16.53% |
| 2019 | 4.19 | -9.93% |
| 2018 | 4.65 | 13.21% |
| 2017 | 4.11 | 10.12% |
| 2016 | 3.73 | -8.56% |
| 2015 | 4.08 | 3.29% |
| 2014 | 3.95 | 6.17% |
| 2013 | 3.72 | 21.34% |
| 2012 | 3.07 | 24.3% |
| 2011 | 2.47 | 19.25% |
| 2010 | 2.07 | -29.52% |
| 2009 | 2.94 | 18.71% |
| 2008 | 2.47 | -22.1% |
| 2007 | 3.17 | -15.22% |
| 2006 | 3.74 | 11.88% |
| 2005 | 3.35 | -12.55% |
| 2004 | 3.83 | -35.85% |
| 2003 | 5.96 | 2.5% |
| 2002 | 5.82 | -24.96% |
| 2001 | 7.75 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 5.04 | 122.59% | 🇺🇸 USA |
 Novartis NVS | 3.69 | 63.16% | 🇨🇭 Switzerland |
 Abbott Laboratories ABT | 3.92 | 73.21% | 🇺🇸 USA |
 Eli Lilly LLY | 11.2 | 393.08% | 🇺🇸 USA |
 Amgen AMGN | 4.80 | 112.16% | 🇺🇸 USA |
 Merck MRK | 4.58 | 102.30% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 3.10 | 37.07% | 🇺🇸 USA |
 AstraZeneca AZN | 4.80 | 112.19% | 🇬🇧 UK |
 GlaxoSmithKline GSK | 1.89 | -16.41% | 🇬🇧 UK |